VINATIORGA
Vinati Organics Limited
Specialty chemicals including ATBS/AMPS monomers and antioxidants
Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals
vinatiorganics.com(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Vinati Organics makes specialty chemicals at Mahad in Maharashtra, led by managing director and CEO Vinati Saraf Mutreja, and sells ATBS (a monomer used in oilfield, water-treatment and other polymers), antioxidants, butyl phenols and isobutylene (IB) derivatives to industrial customers in India and abroad.
Company snapshot
12thBy market cap
Ranked among 68 companies in Specialty Chemicals.
What we see
- ✓Net margin of 19.9% — the business keeps a healthy share of every rupee it earns.
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 448 Cr | 448 Cr | 550 Cr | 525 Cr | 553 Cr | 522 Cr | 648 Cr | 542 Cr | 550 Cr | 531 Cr | 604 Cr | 696 Cr |
| Operating expenses (approx.) | 337 Cr | 333 Cr | 400 Cr | 400 Cr | 420 Cr | 379 Cr | 468 Cr | 382 Cr | 383 Cr | 374 Cr | 434 Cr | 525 Cr |
| EBITDA | 111 Cr | 115 Cr | 150 Cr | 125 Cr | 134 Cr | 142 Cr | 180 Cr | 160 Cr | 167 Cr | 157 Cr | 170 Cr | 170 Cr |
| OPM % | 24.7% | 25.6% | 27.2% | 23.8% | 24.2% | 27.3% | 27.8% | 29.5% | 30.4% | 29.5% | 28.2% | 24.5% |
| Other income | 16 Cr | 9 Cr | 10 Cr | 9 Cr | 22 Cr | 7 Cr | 6 Cr | 7 Cr | 16 Cr | 9 Cr | 20 Cr | 9 Cr |
| Interest | 0.27 Cr | 0.99 Cr | 0.85 Cr | 0.45 Cr | 0.07 Cr | 0.09 Cr | 0.16 Cr | 0.37 Cr | 0.01 Cr | 0.01 Cr | 0.02 Cr | 0.01 Cr |
| Depreciation | 14 Cr | 19 Cr | 20 Cr | 21 Cr | 22 Cr | 22 Cr | 23 Cr | 26 Cr | 26 Cr | 29 Cr | 30 Cr | 32 Cr |
| Profit before tax | 113 Cr | 103 Cr | 139 Cr | 112 Cr | 134 Cr | 127 Cr | 164 Cr | 141 Cr | 157 Cr | 136 Cr | 160 Cr | 148 Cr |
| Tax % | 25.5% | 25.4% | 25.1% | 24.9% | 21.9% | 26.0% | 24.9% | 26.2% | 26.9% | 25.9% | 22.7% | 26.3% |
| Net profit | 84 Cr | 77 Cr | 104 Cr | 84 Cr | 104 Cr | 94 Cr | 123 Cr | 104 Cr | 115 Cr | 101 Cr | 124 Cr | 109 Cr |
| EPS (₹) | ₹8.19 | ₹7.42 | ₹10.05 | ₹8.12 | ₹10.06 | ₹9.04 | ₹11.87 | ₹10.05 | ₹11.08 | ₹9.73 | ₹11.95 | ₹10.50 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 954 Cr | 1,616 Cr | 2,085 Cr | 1,900 Cr | 2,248 Cr | 2,227 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 602 Cr | 1,181 Cr | 1,489 Cr | 1,430 Cr | 1,667 Cr | 1,573 Cr | Sign in free for the trailing twelve months |
| EBITDA | 353 Cr | 434 Cr | 595 Cr | 470 Cr | 581 Cr | 654 Cr | Sign in free for the trailing twelve months |
| OPM % | 36.9% | 26.9% | 28.6% | 24.7% | 25.8% | 29.4% | Sign in free for the trailing twelve months |
| Other income | 26 Cr | 61 Cr | 72 Cr | 39 Cr | 44 Cr | 53 Cr | Sign in free for the trailing twelve months |
| Interest | 0.21 Cr | 0.26 Cr | 0.63 Cr | 4 Cr | 0.52 Cr | 0.41 Cr | Sign in free for the trailing twelve months |
| Depreciation | 43 Cr | 45 Cr | 52 Cr | 73 Cr | 89 Cr | 111 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 335 Cr | 449 Cr | 615 Cr | 432 Cr | 536 Cr | 595 Cr | Sign in free for the trailing twelve months |
| Tax % | 19.7% | 22.8% | 25.6% | 25.2% | 24.4% | 25.4% | Sign in free for the trailing twelve months |
| Net profit | 269 Cr | 347 Cr | 458 Cr | 323 Cr | 405 Cr | 444 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹26.20 | ₹33.72 | ₹44.56 | ₹31.15 | ₹39.09 | ₹42.80 | Sign in free for the trailing twelve months |
| Dividend payout % | 2.1% | 17.8% | 14.6% | 22.4% | 17.9% | 17.6% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 10 Cr | 10 Cr | 10 Cr | 10 Cr | 10 Cr | 10 Cr |
| Reserves | 1,533 Cr | 1,818 Cr | 2,208 Cr | 2,451 Cr | 2,783 Cr | 3,151 Cr |
| Borrowings | 2 Cr | 18 Cr | 0.20 Cr | 5 Cr | 63 Cr | — |
| Other liabilities | 188 Cr | 243 Cr | 329 Cr | 374 Cr | 423 Cr | 428 Cr |
| Total liabilities | 1,734 Cr | 2,090 Cr | 2,547 Cr | 2,840 Cr | 3,279 Cr | 3,590 Cr |
| Fixed assets (net) | 756 Cr | 872 Cr | 881 Cr | 1,488 Cr | 1,724 Cr | 2,122 Cr |
| CWIP | 56 Cr | 51 Cr | 235 Cr | 249 Cr | 438 Cr | 214 Cr |
| Investments | 289 Cr | 94 Cr | 227 Cr | 64 Cr | 36 Cr | 190 Cr |
| Loans & advances | 0.08 Cr | 0.29 Cr | 0.0018 Cr | 0.13 Cr | 0.11 Cr | 0.12 Cr |
| Inventories | 122 Cr | 176 Cr | 191 Cr | 199 Cr | 221 Cr | 311 Cr |
| Trade receivables | 277 Cr | 458 Cr | 470 Cr | 530 Cr | 592 Cr | 521 Cr |
| Cash & bank | 2 Cr | 0.95 Cr | 6 Cr | 0.37 Cr | 0.49 Cr | 4 Cr |
| Other assets | 233 Cr | 437 Cr | 538 Cr | 310 Cr | 267 Cr | 227 Cr |
| Total assets | 1,734 Cr | 2,090 Cr | 2,547 Cr | 2,840 Cr | 3,279 Cr | 3,590 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Cash from operating activity | 219 Cr | 127 Cr | 577 Cr | 332 Cr | 458 Cr | 558 Cr |
| Cash from investing | -198 Cr | -255 Cr | -367 Cr | -348 Cr | -443 Cr | -413 Cr |
| Cash from financing | -3 Cr | -47 Cr | -86 Cr | -108 Cr | -16 Cr | -141 Cr |
| Net cash flow | 18 Cr | -175 Cr | 124 Cr | -125 Cr | 0.12 Cr | 3 Cr |
| Free cash flow (OCF − Capex) | 136 Cr | -47 Cr | 299 Cr | -66 Cr | -42 Cr | 288 Cr |
Ratios
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| ROCE % | 21.7% | 24.3% | 27.8% | 17.7% | 18.8% | 18.8% |
| ROE % | 17.4% | 19.0% | 20.6% | 13.1% | 14.5% | 14.0% |
| Debtor days | 106 | 103 | 82 | 102 | 96 | 85 |
| Inventory days | 107 | 75 | 64 | 72 | 68 | 106 |
| Days payable | 58 | 49 | 40 | 36 | 46 | 41 |
| Cash conversion cycle | 154 | 129 | 106 | 137 | 118 | 150 |
| OCF / EBITDA % | 62.1% | 29.2% | 97.0% | 70.6% | 78.9% | 85.3% |
| OCF / EBITDA % (3 years) | — | — | 66.8% | 69.1% | 83.1% | 79.1% |
| Debt / equity | 0.0013 | 0.01 | 0.0001 | 0.0019 | 0.02 | 0.00 |
| Current ratio | 6.15 | 4.64 | 4.52 | 4.53 | 3.31 | 5.40 |
| Net debt / EBITDA | 0.0010 | 0.04 | -0.0091 | 0.0091 | 0.11 | -0.0058 |